Analysis of MYH Tyr165Cys and Gly382Asp variants in childhood leukemias
Date
2003Source Title
Journal of Cancer Research and Clinical Oncology
Print ISSN
0171-5216
Publisher
Springer
Volume
129
Issue
10
Pages
604 - 605
Language
English
Type
ArticleItem Usage Stats
69
views
views
56
downloads
downloads
Metadata
Show full item recordAbstract
[No abstract available]
Keywords
Aspartic acidCysteine
Glycine
Mutant protein
Protein MYH
Tyrosine
Unclassified drug
Acute granulocytic leukemia
Acute lymphoblastic leukemia
Article
Cancer risk
Childhood leukemia
Controlled study
DNA repair
Excision repair
Gene
Human
Major clinical study
Mismatch repair
Missense mutation
Myh gene
Priority journal
Turkey (republic)
United kingdom
Child
DNA glycosylases
DNA, neoplasm
European continental ancestry group
Humans
Leukemia, lymphocytic, acute
Leukemia, myelocytic, acute
Mutation
Turkey
Permalink
http://hdl.handle.net/11693/24423Published Version (Please cite this version)
http://dx.doi.org/10.1007/s00432-003-0483-1Collections
Related items
Showing items related by title, author, creator and subject.
-
Donor cell leukemia in a patient developing 11 months after an allogeneic bone marrow transplantation for chronic myeloid leukemia
(Wiley, 2006)A 38‐year‐old female with chronic myeloid leukemia underwent an allogeneic bone marrow transplantation from her full‐matched brother. Eleven months later, she readmitted with an acute leukemia that was shown to be of donor ... -
Homozygosity at variant MLH1 can lead to secondary mutation in NF1, neurofibromatosis type I and early onset leukemia
(Elsevier, 2008)Heterozygous germ-line variants of DNA mismatch repair (MMR) genes predispose individuals to hereditary non-polyposis colorectal cancer. Several independent reports have shown that individuals constitutionally homozygous ... -
Selective adsorption of L1210 leukemia cells/human leukocytes on micropatterned surfaces prepared from polystyrene/polypropylene-polyethylene blends
(Elsevier, 2014-01-01)The objective of this study is to prepare polymeric surfaces which will adsorb L1210 leukemia cells selectively more than that of healthy human leukocytes in order to develop new treatment options for people with leukemia. ...
